In a follow-up study to above, Pories et al [54] found that urinary ADAM12 levels were also increased in women with putative premalignant lesions of invasive breast cancer such as atypical hyperplasia and lobular carcinoma in situ, compared to levels in healthy controls. This evidence concerns the gene ADAM12 and breast carcinoma.